GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CompuGroup Medical SE & Co KgaA (XTER:COP) » Definitions » Intrinsic Value: DCF (Dividends Based)

CompuGroup Medical SE KgaA (XTER:COP) Intrinsic Value: DCF (Dividends Based) : €25.37 (As of May. 17, 2024)


View and export this data going back to 2007. Start your Free Trial

What is CompuGroup Medical SE KgaA Intrinsic Value: DCF (Dividends Based)?

As of today (2024-05-17), CompuGroup Medical SE KgaA's intrinsic value calculated from the Discounted Dividend model is €25.37.

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star) with dividend payments. If the company's Predictability Rank is 1-Star or Not Rated, or if the company does not pay dividend, the data will not be stored into our database.

CompuGroup Medical SE KgaA's Predictability Rank is 3.5-Stars.

Margin of Safety % (DCF Dividends Based) using Discounted Dividend Model for CompuGroup Medical SE KgaA is -12.73%.

The historical rank and industry rank for CompuGroup Medical SE KgaA's Intrinsic Value: DCF (Dividends Based) or its related term are showing as below:

XTER:COP' s Price-to-DCF (Dividends Based) Range Over the Past 10 Years
Min: 1.1   Med: 1.96   Max: 6.22
Current: 1.12

During the past 13 years, the highest Price-to-Intrinsic-Value-DCF (Dividends Based) Ratio of CompuGroup Medical SE KgaA was 6.22. The lowest was 1.10. And the median was 1.96.

XTER:COP's Price-to-DCF (Dividends Based) is ranked better than
50.63% of 79 companies
in the Healthcare Providers & Services industry
Industry Median: 1.19 vs XTER:COP: 1.12

CompuGroup Medical SE KgaA Intrinsic Value: DCF (Dividends Based) Historical Data

The historical data trend for CompuGroup Medical SE KgaA's Intrinsic Value: DCF (Dividends Based) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CompuGroup Medical SE KgaA Intrinsic Value: DCF (Dividends Based) Chart

CompuGroup Medical SE KgaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: DCF (Dividends Based)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.79 34.50 35.57 23.85 25.15

CompuGroup Medical SE KgaA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Intrinsic Value: DCF (Dividends Based) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.74 27.24 26.16 25.15 25.51

Competitive Comparison of CompuGroup Medical SE KgaA's Intrinsic Value: DCF (Dividends Based)

For the Health Information Services subindustry, CompuGroup Medical SE KgaA's Price-to-DCF (Dividends Based), along with its competitors' market caps and Price-to-DCF (Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CompuGroup Medical SE KgaA's Price-to-DCF (Dividends Based) Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CompuGroup Medical SE KgaA's Price-to-DCF (Dividends Based) distribution charts can be found below:

* The bar in red indicates where CompuGroup Medical SE KgaA's Price-to-DCF (Dividends Based) falls into.



CompuGroup Medical SE KgaA Intrinsic Value: DCF (Dividends Based) Calculation

This is the intrinsic value calculated from the Discounted Dividend Model with default parameters. The calculation method is the same as Discounted Cash Flow model except adjusted dividend are used in the calculation instead of free cash flow. This is the default method of calculation with GuruFocus DCF calculator.

Usually a two-stage model is used in calculating the intrinsic value with discounted cash flow model. The first stage is called growth stage; the second is called the terminal stage. In the growth stage the company grows at a faster rate. Because it cannot grow at that rate forever, a lower rate is used for the terminal stage.

GuruFocus DDM calculator is a two-stage model. The default values are defined as:

1. Discount Rate: d = 9%
A reasonable discount rate assumption should be at least the long term average return of the stock market, which can be estimated from risk free rate plus risk premium of stock market. GuruFocus uses 10-Year Treasury Constant Maturity Rate as the risk-free rate and rounded up to the nearest integer. It is updated daily. The current risk-free rate is 2.44%. Please go to Economic Indicators page for more information. Please note that we use the 10-Year Treasury Constant Maturity Rate of the country/region where the company is headquartered. If the data for that country/region is not available, then we will use the 10-Year Treasury Constant Maturity Rate of the United States as default. Then we added a risk premium of 6% to get the estimated discount rate. Some investors use their expected rate of return, which is also reasonable. A typical discount rate can be anywhere between 6% - 20%.

2. Dividend Growth Rate in the growth stage: g1 = 5.00%
The Growth Rate in the growth stage is initially set as the default 10-Year Dividend Growth Rate. In cases where the 10-year growth rate is unavailable, it defaults to using the 5-Year Dividend Growth Rate. If both the 10-year and 5-year growth rates are unavailable, the system defaults to the 3-Year Dividend Growth Rate.
However, it's important to note that there is a growth rate range. If the calculated growth rate exceeds 20%, it will be capped at 20%. Conversely, if the calculated growth rate falls below 5%, it will be adjusted to 5% to maintain a reasonable range.
=> CompuGroup Medical SE KgaA's average Dividend Growth Rate in the past 10 years was 5.00%, which is between 5% and 20%. => GuruFocus defaults => Growth Rate: 5.00%

3. Years of Growth Stage: y1 = 10

4. Terminal Growth Rate: g2 = 4%

5. Dividends per Share: adjusted dividends per share = €1.872.
GuruFocus uses adjusted dividends per share by default to ensure that the valuation reflects the total value of the company, as the actual dividend is only a portion of the total value.

All of the default settings can be changed in the DCF calculator and the results are calculated automatically.

CompuGroup Medical SE KgaA's Intrinsic Value: DCF (Dividends Based) for today is calculated as:

Intrinsic Value: DCF (Dividends Based)=Dividends per Share*{[(1+g1)/(1+d)+(1+g1)^2/(1+d)^2+...+(1+g1)^10/(1+d)^10]
+(1+g1)^10/(1+d)^10*[(1+g2)/(1+d)+(1+g2)^2/(1+d)^2+...+(1+g2)^10/(1+d)^10]}

set x = (1+g1)/(1+d) = (1+0.05)/(1+0.09) = 0.96330275229358
and y = (1+g2)/(1+d) = (1+0.04)/(1+0.09) = 0.95412844036697

Intrinsic Value: DCF (Dividends Based)=Dividends per Share*{[x+x^2+...+x^10]+x^10*[y+y^2+...+y^10]}
=Dividends per Share*[x*(1-x^10)/(1-x)+x^10*y*(1-y^10)/(1-y)]
=1.872*13.5514
=25.37

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based)-Current Price) /Intrinsic Value: DCF (Dividends Based)
= (25.37 - 28.60) / 25.37
= -12.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CompuGroup Medical SE KgaA  (XTER:COP) Intrinsic Value: DCF (Dividends Based) Explanation

Unlike valuation methods such as Net Current Asset Value, Tangible Book per Share, Graham Number, Median PS Value etc, discounted Dividends model evaluates the companies based on their power of future dividend distribution instead of their assets.


Be Aware

What you need to know about Discounted Dividends model:

1. The Discounted Dividends model evaluates a company based on its future dividends distribution power
2. Dividend growth is taken into account; therefore a company with a higher dividend growth rate is worth more if everything else is the same.
3. Since we are projecting future growth, it is assumed that the company will grow at the same rate as it did during the past 10 years. Therefore this model works better for the companies with consistently steady dividends distributed.
4. The Discounted Dividends model works poorly for inconsistent dividends distributor like high growth companies.
5. Your expected return from the investment is a reasonable discount rate assumption.
6. A larger margin of safety should be required for companies with less dividends distributed.

You can screen for stocks that trade below their Intrinsic Value: DCF (FCF Based) and Intrinsic Value: DCF (Earnings Based) and Intrinsic Value: DCF (Dividends Based) with the GuruFocus All-in-One Screener. Companies with a high Predictability Rank that trade at a discount to their Intrinsic Value: DCF (FCF Based) and Intrinsic Value: DCF (Earnings Based) can be found in the screen of Undervalued Predictable Companies.


CompuGroup Medical SE KgaA Intrinsic Value: DCF (Dividends Based) Related Terms

Thank you for viewing the detailed overview of CompuGroup Medical SE KgaA's Intrinsic Value: DCF (Dividends Based) provided by GuruFocus.com. Please click on the following links to see related term pages.


CompuGroup Medical SE KgaA (XTER:COP) Business Description

Traded in Other Exchanges
Address
Maria Trost 21, Koblenz, DEU, 56070
CompuGroup Medical SE & Co KgaA provides electronic health solutions to healthcare providers through four segments: Ambulatory information systems, Pharmacy information systems, Hospital information systems, and Consumer and Health Management Information Systems. The Ambulatory information systems segment contributes to the majority of revenue and provides practice management software and electronic medical record management. Pharmacy information systems provide clinical, administrative, and financial software for retail pharmacies. The Hospital information systems segment sells its solutions to in-patient centers. Consumer and Health Management Information Systems offers networking service connect providers and other market participants.
Executives
Michael Rauch Managing director of the general partner of the issuer
Emanuele Mugnani Managing director of the general partner of the issuer
Frank Gotthardt Chairman of Administrative Board of CompuGroup Medical Management SE
Prof. (apl.) Dr. Med Daniel Gotthardt Member of the Administrative Board of CompuGroup Medical Management SE
Hannes Reichl Managing director of the general partner of the issuer
Dr. Eckart Pech Managing director of the general partner of the issuer
Dr. Dirk Wössner CEO, Managing director of the general partner of the issuer
Dr. Ralph Körfgen Managing director of the general partner of the issuer

CompuGroup Medical SE KgaA (XTER:COP) Headlines

From GuruFocus

Q3 2022 Conocophillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

Conocophillips Analyst & Investor Meeting Transcript

By GuruFocus Research 01-22-2024

Q3 2023 Conocophillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

ConocoPhillips Annual Shareholders Meeting Transcript

By GuruFocus Research 01-22-2024

Q4 2022 Conocophillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2020 ConocoPhillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

ConocoPhillips Annual Shareholders Meeting Transcript

By GuruFocus Research 01-22-2024

Q2 2019 ConocoPhillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2023 Conocophillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2020 ConocoPhillips Earnings Call Transcript

By GuruFocus Research 01-22-2024